Jonas Jae-Hyun P.
- Country
- Germany
- Department
- St. Josefs Hospital
Research Overview
Data & Insights
Has run more than one trial at 0 of 66 partner sites.
Specializations
Hematologic Malignancies
Investigator concentrates on aggressive blood cancers including Acute lymphoblastic leukemia, Acute myeloid leukemia, Chronic lymphocytic leukemia, Mantle cell lymphoma, and Multiple myeloma.
- Risk‑adapted therapy for Philadelphia‑positive acute lymphoblastic leukemia
- High‑risk chronic lymphocytic leukemia management
- Novel consolidation approaches in mantle cell lymphoma
Emphasis on improving survival outcomes across diverse hematologic entities.
Targeted Molecular Therapy
Focus on agents that inhibit oncogenic drivers such as BCR‑ABL1, BTK, and BCL‑2 across multiple disease settings.
- BTK inhibition combined with anti‑CD20 antibodies
- BCR‑ABL1 tyrosine‑kinase inhibition in frontline regimens
- BCL‑2 antagonism alongside standard chemotherapy
Integrates precision medicine principles to tailor treatment.
Immunotherapy & Cellular Approaches
Investigates checkpoint blockade and bispecific T‑cell engagers to enhance antitumor immunity in both hematologic and solid tumors.
- PD‑L1 blockade combined with novel vaccine platforms
- Use of bispecific T‑cell engagers in acute lymphoblastic leukemia
- Evaluation of checkpoint inhibition in HPV‑positive head and neck cancer
Aims to expand immunologic control beyond conventional chemotherapy.
Stem Cell Transplantation Strategies
Develops conditioning and maintenance protocols to optimize autologous hematopoietic stem‑cell transplantation and allogeneic transplantation outcomes.
- Post‑transplant maintenance with targeted agents
- Risk‑stratified conditioning for autologous transplantation
- Integration of novel agents in allogeneic transplantation setting
Seeks to reduce relapse rates while preserving graft function.
Head & Neck Oncology
Addresses advanced head and neck squamous cell carcinoma, focusing on metastatic and recurrent disease.
- Combination of PD‑L1 inhibition with radiotherapy
- Therapeutic sequencing for recurrent disease
- Biomarker‑driven trials in HPV‑positive tumors
Targets improvement of long‑term disease control.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.